Imaging phenotypes of breast cancer heterogeneity in preoperative breast dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) scans predict 10-year recurrence

Rhea D. Chitalia, Jennifer Rowland, Elizabeth S. McDonald, Lauren Pantalone, Eric A. Cohen, Aimilia Gastounioti, Michael Feldman, Mitchell Schnall, Emily Conant, Despina Kontos

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Abstract

Purpose: Identifying imaging phenotypes and understanding their relationship with prognostic markers and patient outcomes can allow for a noninvasive assessment of cancer. The purpose of this study was to identify and validate intrinsic imaging phenotypes of breast cancer heterogeneity in preoperative breast dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) scans and evaluate their prognostic performance in predicting 10 years recurrence. Experimental Design: Pretreatment DCE-MRI scans of 95 women with primary invasive breast cancer with at least 10 years of follow-up from a clinical trial at our institution (2002–2006) were retrospectively analyzed. For each woman, a signal enhancement ratio (SER) map was generated for the entire segmented primary lesion volume from which 60 radiomic features of texture and morphology were extracted. Intrinsic phenotypes of tumor heterogeneity were identified via unsupervised hierarchical clustering of the extracted features. An independent sample of 163 women diagnosed with primary invasive breast cancer (2002–2006), publicly available via The Cancer Imaging Archive, was used to validate phenotype reproducibility. Results: Three significant phenotypes of low, medium, and high heterogeneity were identified in the discovery cohort and reproduced in the validation cohort (P < 0.01). Kaplan–Meier curves showed statistically significant differences (P < 0.05) in recurrence-free survival (RFS) across phenotypes. Radiomic phenotypes demonstrated added prognostic value (c ¼ 0.73) predicting RFS. Conclusions: Intrinsic imaging phenotypes of breast cancer tumor heterogeneity at primary diagnosis can predict 10-year recurrence. The independent and additional prognostic value of imaging heterogeneity phenotypes suggests that radiomic phenotypes can provide a noninvasive characterization of tumor heterogeneity to augment personalized prognosis and treatment.

Original languageEnglish
Pages (from-to)862-869
Number of pages8
JournalClinical Cancer Research
Volume26
Issue number4
DOIs
StatePublished - Feb 15 2020

Fingerprint

Dive into the research topics of 'Imaging phenotypes of breast cancer heterogeneity in preoperative breast dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) scans predict 10-year recurrence'. Together they form a unique fingerprint.

Cite this